First-line immunotherapy versus BRAF and MEK inhibitors for patients with BRAF V600E mutant metastatic non-small cell lung cancer Meeting Abstract
| Authors: | Di Federico, A.; Chen, M. F.; Pagliaro, A.; Ogliari, F. R.; Stockhammer, P.; Aldea, M.; Grant, M.; De Giglio, A.; Alessi, J. V.; Pecci, F.; Gelsomino, F.; Negrao, M. V.; Ferrara, R.; Awad, M.; Riely, G. J.; Ardizzoni, A.; Planchard, D.; Offin, M. D.; Johnson, B. E.; Ricciuti, B. |
| Abstract Title: | First-line immunotherapy versus BRAF and MEK inhibitors for patients with BRAF V600E mutant metastatic non-small cell lung cancer |
| Meeting Title: | ESMO Congress 2024 |
| Journal Title: | Annals of Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sep 13-17 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-09-01 |
| Start Page: | S826 |
| End Page: | S827 |
| Language: | English |
| ACCESSION: | WOS:001326612901601 |
| DOI: | 10.1016/j.annonc.2024.08.1356 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1299P -- Source: Wos |
